| 规格: | 98% |
| 分子量: | 504.52 |
| 包装 | 价格(元) |
| 250mg | 电议 |
| 500mg | 电议 |
Background:
Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy.
Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy[1].
[1]. Kobayashi, et al. Therapeutic agent for neuroparalytic keratopathy containing benzisoxazol compound-?based PPARδ agonist. WO2016199871A1.
m.cnreagent.com